<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e> and <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e> are <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> resulting in <z:hpo ids='HP_0008873'>short-limbed dwarfism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Histologic and ultrastructural studies of the cartilage in <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e> and in homozygous <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> have suggested a structural abnormality in <z:chebi fb="0" ids="37397">chondroitin sulfate</z:chebi> <z:chebi fb="0" ids="37396">proteoglycan</z:chebi> (CSPG), a major structural protein in the extra-cellular matrix </plain></SENT>
<SENT sid="2" pm="."><plain>The gene encoding CSPG core protein (CSPGCP) is thus a logical "candidate gene" for analysis in these conditions </plain></SENT>
<SENT sid="3" pm="."><plain>cDNA probes encoding CSPGCP were used to identify restriction fragment length polymorphisms (RFLPs) in DNA from a panel of control individuals </plain></SENT>
<SENT sid="4" pm="."><plain>No gross alterations at the CSPGCP locus were noted in DNA from 37 individuals with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and 5 individuals with <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, allelic frequencies of the RFLPs were not significantly different among controls and patients with either condition </plain></SENT>
<SENT sid="6" pm="."><plain>In one three-generation family with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, close linkage of the CSPGCP locus and the <z:hpo ids='HP_0002652'>skeletal dysplasia</z:hpo> was excluded using a Bgl II polymorphism </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, in a three-generation family with <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e>, the CSPGCP gene was not tightly linked to the disease phenotype </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate that mutations at the <z:chebi fb="0" ids="37397">chondroitin sulfate</z:chebi> <z:chebi fb="0" ids="37396">proteoglycan</z:chebi> core protein locus do not cause <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> or <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e> in these families </plain></SENT>
</text></document>